Prognostic value of myosteatosis and systemic inflammation in patients with resectable gastric cancer: A retrospective study.
Fabiana LascalaBruna Karoline da Silva MoraesMaria Carolina Santos MendesMariluce Barbosa de CarvalhoSandra Regina BranbillaAdemar Dantas da Cunha JúniorLuiz Roberto LopesNelson Adami AndreolloLígia Traldi MacedoCarla M PradoJosé Barreto Campello CarvalheiraPublished in: European journal of clinical nutrition (2022)
Co-occurrence of myosteatosis and inflammation increased disease progression and death risk by almost three times. These regularly obtained biomarkers might improve prognostic risk prediction in resectable GC.